本則回應

• Lopi標記此篇為：💬 含有個人意見

  理由

  (1)本文報導跟主要媒體報導，大致一樣. 有些地方則是作者自己的引申猜測，澄清如下:
  (2)文中稱“輝瑞公開專利，允許世界各國無償製造”為不實。輝瑞僅授權給聯合國MPP(中低收入)成員國無償製造。參考[1]
  (3)文中稱“Paxlovid可以在藥房裡買到，回家自己服用的膠囊💊”為假
  閱讀更多

  不同意見

  [1]路透社 https://www.reuters.com/business/healthc⋯s-covid-19-pill-95-countries-2021-11-16/
  [2]FDA https://www.fda.gov/news-events/press-an⋯-first-oral-antiviral-treatment-covid-19
  

  Pfizer to allow generic versions of its COVID pill in 95 countries

  https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-allow-generic-versions-its-covid-19-pill-95-countries-2021-11-16/

  Pfizer Inc said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with internationa

  Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19

  Today, the FDA issued an EUA for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients.